Fundraising Fox

Celsius Therapeutics

acquired by AbbVie

Cambridge, US · Founded 2017 · Delaware corporation · 2 known investors

Combines single-cell RNA analysis technology from the Broad Institute with AI/ML models and large-scale clinical sample collection for novel drug discovery and precision medicine. Acquired by AbbVie Inc. in June 2024.

Healthtech

Founders & leadership

MB
Michael BorettiExecutive Officer
TK
Tariq KassumExecutive Officer, Director
CL
Christoph LengauerExecutive Officer, Director

Investors · 2

Catalio Capital Management, LPNew York
Fast Track InitiativeTokyo · $1.2M – $184M

Reported raises · per SEC filings

Form D private placements
▶$48MraisedOct 2019 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael BorettiExecutive Officer
  • Tariq KassumExecutive Officer, Director
  • Christoph LengauerExecutive Officer, Director
Offering amount
$65M
Amount sold
$48M
First sale
May 2018
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.